EUVIMEDEUVIMED entdecken
CrossrefInfokarte

Medical Case Report: Autosomal Recessive Progressive Pseudorheumatoid Dysplasia

Nada Alchama, Raneem Alawa, Mouaz Zuraik

Annals of Rheumatology and Autoimmunity · 2026

DOI: 10.4103/ara.ara_12_25 ↗
AbstractBibliografische Angaben

Abstract

Abstract Progressive pseudorheumatoid dysplasia (PPRD) is a rare genetic skeletal disorder characterized by the progressive degeneration of articular cartilage, resulting in joint pain, stiffness, and deformities. Due to its rarity, the majority of available knowledge comes from isolated case reports, with limited larger case series. This case report presents an 18-year-old female who was initially misdiagnosed with juvenile idiopathic arthritis due to overlapping joint symptoms and was referred for potential biologic therapy. The patient had a history of progressive joint pain and deformities starting at a young age. Genetic testing revealed a homozygous mutation in the CCN6 gene, confirming a diagnosis of autosomal recessive PPRD. PPRD should be considered when a patient presents with symmetrical joint involvement, characteristic knobby interphalangeal joints, and gait abnormalities, particularly in the absence of systemic inflammation. Radiological features, such as joint space narrowing and sclerosis, along with negative autoantibodies, can guide the diagnosis. Genetic testing, including the analysis of genomic DNA and mRNA, is crucial for confirmation. Early recognition of PPRD is essential to avoid unnecessary immunosuppressive treatments and to provide appropriate management, including symptom relief and orthopedic support.

Wissen, das zu Ihrer Arbeit passt.

Vom kostenlosen Einstieg über die persönliche Recherche bis zur vollständigen Research Suite.

Tarife ansehen →

Sind alle Verlagsvolltexte enthalten?

Nein. Bibliografische Nachweise, Abstracts und Volltexte sind unterschiedliche Inhalte. Ob ein Volltext verfügbar ist, hängt von der Quelle, Open Access und Ihren vorhandenen Lizenzen ab. Ein EUVIMED-Tarif ersetzt keine zusätzlichen Verlagsrechte.

Tarife ansehen →